Title
|
|
|
|
Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups
|
|
Author
|
|
|
|
|
|
Language
|
|
|
|
English
|
|
Source (journal)
|
|
|
|
Leukemia. - Baltimore, Md, 1987, currens
|
|
Publication
|
|
|
|
Baltimore, Md
:
2005
|
|
ISSN
|
|
|
|
0887-6924
[print]
1476-5551
[online]
|
|
DOI
|
|
|
|
10.1038/SJ.LEU.2403901
|
|
Volume/pages
|
|
|
|
19
:10
(2005)
, p. 1768-1773
|
|
ISI
|
|
|
|
000232204000008
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|